O-022 General Anesthesia, Baseline ASPECTS, Time to Treatment, and IV TPA Impact Intracranial Hemorrhage after Stentriever Thrombectomy: Pooled Analysis from SWIFT PRIME, SWIFT and STAR Trials. (29th July 2016)
- Record Type:
- Journal Article
- Title:
- O-022 General Anesthesia, Baseline ASPECTS, Time to Treatment, and IV TPA Impact Intracranial Hemorrhage after Stentriever Thrombectomy: Pooled Analysis from SWIFT PRIME, SWIFT and STAR Trials. (29th July 2016)
- Main Title:
- O-022 General Anesthesia, Baseline ASPECTS, Time to Treatment, and IV TPA Impact Intracranial Hemorrhage after Stentriever Thrombectomy: Pooled Analysis from SWIFT PRIME, SWIFT and STAR Trials
- Authors:
- Raychev, R
Saver, J
Jahan, R
Nogueira, R
Goyal, M
Pereira, V
Gralla, J
Levy, E
Yavagal, D
Cognard, C
Liebeskind, D - Abstract:
- Abstract : Introduction: Despite the proven benefit of Solitaire for treatment of acute ischemic stroke, symptomatic intracranial hemorrhage (ICH) remains the most feared procedural complication. The aim of this analysis was to identify the factors determining ICH after neurothrombectomy with Solitaire stentriever. Methods: All patients (N = 389) treated with Solitaire in SWIFT, SWIFT PRIME, and STAR trials were analyzed for incidence of 5 different ICH subtypes. Each ICH subtype was correlated with baseline clinical, imaging and procedural characteristic (age, NIHSS, hypertension, diabetes, atrial fibrillation, hyperglycemia, INR, platelet count, ASPECTS, general anesthesia, collateral grade, number of devices passes, final TICI, rescue therapy, IV TPA). Multivariate stepwise logistic regression model was used to identify the predictors of individual ICH subtypes. Results: ICH was observed in 21.6% (N = 84) of which sICH was 1.0% (N = 4), hemorrhage in ischemic territory (HIT) 19.3% (N = 75), PH 5.4% (N = 21), and SAH 2.3% (N = 9). The most significant predictors of any ICH, HIT, and PH are included in Table 1 . No specific predictors of SAH, and sICH were identified. Patients who achieved functional independence at 90 days (mRS 0–2) had significantly lower incidence of any ICH, HIT, PH, and no SICH (Table 2 ). Conclusions: Higher baseline ASPECTS, better collaterals and general anesthesia are associated with lower incidence of ICH after neurothrombectomy with SolitaireAbstract : Introduction: Despite the proven benefit of Solitaire for treatment of acute ischemic stroke, symptomatic intracranial hemorrhage (ICH) remains the most feared procedural complication. The aim of this analysis was to identify the factors determining ICH after neurothrombectomy with Solitaire stentriever. Methods: All patients (N = 389) treated with Solitaire in SWIFT, SWIFT PRIME, and STAR trials were analyzed for incidence of 5 different ICH subtypes. Each ICH subtype was correlated with baseline clinical, imaging and procedural characteristic (age, NIHSS, hypertension, diabetes, atrial fibrillation, hyperglycemia, INR, platelet count, ASPECTS, general anesthesia, collateral grade, number of devices passes, final TICI, rescue therapy, IV TPA). Multivariate stepwise logistic regression model was used to identify the predictors of individual ICH subtypes. Results: ICH was observed in 21.6% (N = 84) of which sICH was 1.0% (N = 4), hemorrhage in ischemic territory (HIT) 19.3% (N = 75), PH 5.4% (N = 21), and SAH 2.3% (N = 9). The most significant predictors of any ICH, HIT, and PH are included in Table 1 . No specific predictors of SAH, and sICH were identified. Patients who achieved functional independence at 90 days (mRS 0–2) had significantly lower incidence of any ICH, HIT, PH, and no SICH (Table 2 ). Conclusions: Higher baseline ASPECTS, better collaterals and general anesthesia are associated with lower incidence of ICH after neurothrombectomy with Solitaire stentriever. Prolonged time to treatment increases the risk of parenchymal hematoma and hemorrhage in ischemic territory. Parenchymal hematoma is distinctly associated with IV TPA. Of all ICH subtypes, sICH has the strongest impact on functional independence. Disclosures: R. Raychev: None. J. Saver: 2; C; Medtronic, Stryker, Boehrniger, Neuravia. R. Jahan: 1; C; Medtronic. 2; C; Medtronic. R. Nogueira: 2; C; Medtronic, Stryker. M. Goyal: 2; C; Medtronic. V. Pereira: 2; C; Medtronic, Stryker. J. Gralla: 2; C; Medtronic. E. Levy: 2; C; Pulsar, Blockade Medical LLC Medina Medical Inc, . 4; C; Intratech Medical, Ltd Blockade Medical LLC. D. Yavagal: 2; C; Medtronic. C. Cognard: 2; C; Medtronic, Stryker, Microvention. D. Liebeskind: 2; C; Medtronic, Stryker. … (more)
- Is Part Of:
- Journal of neurointerventional surgery. Volume 8(2016)Supplement 1
- Journal:
- Journal of neurointerventional surgery
- Issue:
- Volume 8(2016)Supplement 1
- Issue Display:
- Volume 8, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 8
- Issue:
- 1
- Issue Sort Value:
- 2016-0008-0001-0000
- Page Start:
- A14
- Page End:
- A15
- Publication Date:
- 2016-07-29
- Subjects:
- Nervous system -- Surgery -- Periodicals
Cerebrovascular disease -- Surgery -- Periodicals
617.48 - Journal URLs:
- http://www.bmj.com/archive ↗
http://jnis.bmj.com/ ↗ - DOI:
- 10.1136/neurintsurg-2016-012589.22 ↗
- Languages:
- English
- ISSNs:
- 1759-8478
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18902.xml